You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Avelox in Sodium Chloride 0.8% in plastic container Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Avelox In Sodium Chloride 0.8% In Plastic Container, and when can generic versions of Avelox In Sodium Chloride 0.8% In Plastic Container launch?

Avelox In Sodium Chloride 0.8% In Plastic Container is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER is moxifloxacin hydrochloride. There are eighteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the moxifloxacin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Avelox In Sodium Chloride 0.8% In Plastic Container

A generic version of Avelox in Sodium Chloride 0.8% in plastic container was approved as moxifloxacin hydrochloride by TEVA PHARMS USA on February 18th, 2014.

  Try a Trial

Summary for Avelox in Sodium Chloride 0.8% in plastic container
Drug patent expirations by year for Avelox in Sodium Chloride 0.8% in plastic container
Recent Clinical Trials for Avelox in Sodium Chloride 0.8% in plastic container

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Daiichi Sankyo, Inc.Phase 4
Usona InstitutePhase 1
Center for Bioequivalence Studies and Clinical ResearchPhase 1

See all Avelox in Sodium Chloride 0.8% in plastic container clinical trials

US Patents and Regulatory Information for Avelox in Sodium Chloride 0.8% in plastic container

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER moxifloxacin hydrochloride SOLUTION;INTRAVENOUS 021277-001 Nov 30, 2001 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Avelox in Sodium Chloride 0.8% in plastic container

International Patents for Avelox in Sodium Chloride 0.8% in plastic container

See the table below for patents covering Avelox in Sodium Chloride 0.8% in plastic container around the world.

Country Patent Number Title Estimated Expiration
Australia 7299194 ⤷  Try a Trial
Slovakia 282805 ⤷  Try a Trial
China 1097759 ⤷  Try a Trial
Czech Republic 298768 Vodný přípravek moxifloxacinu a chloridu sodného, způsob jeho výroby a jeho použití (Aqueous preparation of moxifloxacin and sodium chloride, process of its preparation and use) ⤷  Try a Trial
Croatia P960558 NEW CRYSTALLINE MODIFICATIONS OF CDCH, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for Avelox in Sodium Chloride 0.8% in plastic container

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0350733 300111 Netherlands ⤷  Try a Trial
0780390 PA2004012,C0780390 Lithuania ⤷  Try a Trial PRODUCT NAME: MOXIFLOXACINI HYDROCHLORIDUM (1-CIKLOPROPIL-6-FLUOR-1,4-DIHIDRO-8-METOKSI-7-((4AS, 7AS)-OKTAHIDRO-6H-PIROLO(3,4-B)PIRIDIN-6-IL)-4-OKSO-3-CHINOLINKARBOKSIRUGSTIES HIDROCHLORIDAS); REGISTRATION NO/DATE: 04/8383/3 20040309
0350733 11/2000 Austria ⤷  Try a Trial PRODUCT NAME: MOXIFLOXACIN, DESSEN PHARMAZEUTISCH VERWENDBARE HYDRATE UND SAEUREADDITIONSSALZE, DESSEN ALKALI-ERDALKALI-SILBER- UND GUANIDINIUMSALZE, SOWIE DESSEN C1 - C4 ALKYL- ODER; NAT. REGISTRATION NO/DATE: 1-23494, 1-23495, 1-23496 20000215; FIRST REGISTRATION: DE 45263.00.00 19990621
0350733 SPC/GB03/034 United Kingdom ⤷  Try a Trial PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313
0350733 C300111 Netherlands ⤷  Try a Trial PRODUCT NAME: MOXIFLOXACINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER MOXIFLOXACINEHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 28118 RVG 28119 20021017; FIRST REGISTRATION: DE 45263.00.00 19990621
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.